Effect of centrally acting drugs on experimental torticollis in monkeys.
D000085:Acetates / Q000627:therapeutic use*; D000470:Alkaloids / Q000627:therapeutic use*; D000625:Aminooxyacetic Acid / Q000627:therapeutic use*; D000818:Animals; D001933:Brain Stem / Q000473:pathology; D002522:Chlorocebus aethiops; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004576:Electromyography; D006220:Haloperidol / Q000627:therapeutic use*; D000882:Haplorhini; D006246:Harmaline / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008253:Macaca mulatta; D008781:Methyltyrosines / Q000627:therapeutic use; D009129:Muscle Tonus; D010868:Pimozide / Q000627:therapeutic use; D013681:Tegmentum Mesencephali / Q000503:physiopathology; D014103:Torticollis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology
D000085:Acetates; D000470:Alkaloids; D008781:Methyltyrosines; D000625:Aminooxyacetic Acid; D010868:Pimozide; D007980:Levodopa; D006246:Harmaline; D006220:Haloperidol